| 1 |
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al. · Cell
Open access |
Oct 2017 |
7,867 |
| 2 |
Applications of machine learning in drug discovery and development
Jessica J. Vamathevan, Dominic A. Clark, Paul Czodrowski et al. · Nature Reviews Drug Discovery
ReviewOpen access |
11 Apr 2019 |
3,274 |
| 3 |
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding
Gabriela P. Saborı́o, Bruno Permanne, Claudio A. Soto · Nature
|
14 Jun 2001 |
1,317 |
| 4 |
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman, Jeffery Scott Russell, Omid Hamid et al. · The Lancet Oncology
Open access |
7 Sep 2016 |
1,235 |
| 5 |
An empirical correlation of second virial coefficients
Constantine Tsonopoulos · AIChE Journal
|
Mar 1974 |
971 |
| 6 |
Ultrasonic Atomization of Liquids
Robert J. Lang · The Journal of the Acoustical Society of America
|
1962 |
903 |
| 7 |
Dual specificity phosphatases: a gene family for control of MAP kinase function
Montserrat Camps, ANTON NICHOLS, Steve Arkinstall · The FASEB Journal
|
2000 |
818 |
| 8 |
The Bcl-2 Protein Family
Bruno E. Antonsson, Jean‐Claude Martinou · Experimental Cell Research
Open access |
Apr 2000 |
792 |
| 9 |
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
Amanda E. I. Proudfoot, Tracy M. Handel, Zoë Johnson et al. · Proceedings of the National Academy of Sciences
Open access |
5 Feb 2003 |
788 |
| 10 |
The minimum information about a proteomics experiment (MIAPE)
Chris F. Taylor et al. · Nature Biotechnology
Open access |
Aug 2007 |
782 |
| 11 |
Probability Model for Estimating Three-Phase Relative Permeability
Howard Stone · Journal of Petroleum Technology
Open access |
Feb 1970 |
776 |
| 12 |
Chemokine receptors: multifaceted therapeutic targets
Amanda E. I. Proudfoot · Nature reviews. Immunology
ReviewOpen access |
Feb 2002 |
770 |
| 13 |
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Yves Dirix, István Takács, Guy Jérusalem et al. · Breast Cancer Research and Treatment
Open access |
23 Oct 2017 |
764 |
| 14 |
A continuum theory for granular materials
M.A. Goodman, Stephen C. Cowin · Archive for Rational Mechanics and Analysis
|
1972 |
735 |
| 15 |
Bax Is Present as a High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic Cells
Bruno E. Antonsson, Sylvie Montessuit, Belén G. Sánchez et al. · Journal of Biological Chemistry
Open access |
Apr 2001 |
676 |
| 16 |
Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria
Bruno E. Antonsson, Sylvie Montessuit, Sandra Lauper et al. · Biochemical Journal
Open access |
10 Jan 2000 |
630 |
| 17 |
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Manish R. Patel, John Allan Ellerton, Jeffrey R. Infante et al. · The Lancet Oncology
Open access |
5 Dec 2017 |
591 |
| 18 |
Computation of modal solutions in layered, elastic media at high frequencies
John W. Dunkin · Bulletin of the Seismological Society of America
|
Apr 1965 |
561 |
| 19 |
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem et al. · Annals of Oncology
Open access |
23 Jul 2018 |
508 |
| 20 |
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
Daniel D. Mikol, Frederik Barkhof, Peter Chang et al. · The Lancet Neurology
|
12 Sep 2008 |
487 |
| 21 |
Supported ?bimetallic cluster? catalysts
John H. Sinfelt · Journal of Catalysis
|
May 1973 |
484 |
| 22 |
Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice
Matthias Mack, Josef Cihak, Christopher Simonis et al. · The Journal of Immunology
|
Apr 2001 |
474 |
| 23 |
Predicting Two-Phase Pressure Drops in Vertical Pipe
J. Orkiszewski · Journal of Petroleum Technology
Open access |
Jun 1967 |
454 |
| 24 |
Response Factors for Gas Chromatographic Analyses
Werner Dietz · Journal of Chromatographic Science
|
Feb 1967 |
450 |
| 25 |
Priorities in Parkinson's disease research
Wassilios G. Meissner, Mark A. Frasier, Thomas Gasser et al. · Nature Reviews Drug Discovery
Review |
29 Apr 2011 |
435 |
| 26 |
A Branch-Bound Algorithm for Plant Location
M. A. Efroymson, T. L. Ray · Operations Research
|
Jun 1966 |
426 |
| 27 |
LAMINA, LAMINASET, BED AND BEDSET
Charles V. Campbell · Sedimentology
|
Feb 1967 |
420 |
| 28 |
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Fabrice Barlési, Johan Vansteenkiste, David Robert Spigel et al. · The Lancet Oncology
|
24 Sep 2018 |
400 |
| 29 |
Study of intra- and interlaboratory variability in the results of rabbit eye and skin irritation tests
Carrol S. Weil, Robert A. Scala · Toxicology and Applied Pharmacology
|
Jun 1971 |
391 |
| 30 |
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
Sandra P. D’Angelo, Jeffery Scott Russell, Célèste Lebbé et al. · JAMA Oncology
Open access |
22 Mar 2018 |
376 |
| 31 |
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Niels R. Veillard, Brenda Renata Kwak, Graziano Pelli et al. · Circulation Research
Open access |
Dec 2003 |
375 |
| 32 |
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin et al. · Nature Reviews Drug Discovery
Review |
13 Dec 2019 |
367 |
| 33 |
Cellular imaging in drug discovery
Paul Lang, Karen Yeow, Anthony Charles Nichols et al. · Nature Reviews Drug Discovery
Review |
31 Mar 2006 |
354 |
| 34 |
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis
Marc C. Hochberg, Ali Guermazi, Hans Guehring et al. · JAMA
Open access |
8 Oct 2019 |
353 |
| 35 |
Longitudinal Acoustical Vibrations of Finite Polymethylene Chains
Robert F. Schaufele, Takehiko Shimanouchi · The Journal of Chemical Physics
|
Nov 1967 |
349 |
| 36 |
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Gavin Giovannoni, Per Soelberg Sørensen, Stuart D. Cook et al. · Multiple Sclerosis Journal
Open access |
5 Sep 2017 |
344 |
| 37 |
Protein misfolding and disease; protein refolding and therapy
Claudio A. Soto · FEBS Letters
|
8 Jun 2001 |
340 |
| 38 |
Specificity in Catalytic Hydrogenolysis by Metals
John H. Sinfelt · Advances in catalysis
Book chapter |
1973 |
340 |
| 39 |
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
Ludwig Kappos, Hans‐Peter Hartung, Mark Steven Freedman et al. · The Lancet Neurology
|
6 Mar 2014 |
337 |
| 40 |
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Howard L. Kaufman, Jeffery Scott Russell, Omid Hamid et al. · Journal for ImmunoTherapy of Cancer
Open access |
16 Jan 2018 |
335 |
| 41 |
Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion
Bruno E. Antonsson · Cell and Tissue Research
|
30 Oct 2001 |
334 |
| 42 |
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young‐Hee Lee et al. · Cell Research
Open access |
7 Jul 2017 |
332 |
| 43 |
Considerations in the development of circulating tumor cell technology for clinical use
David Parkinson et al. · Journal of Translational Medicine
Open access |
2 Jul 2012 |
327 |
| 44 |
Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects
Christina Schindler et al. · Journal of Chemical Information and Modeling
|
19 Aug 2020 |
322 |
| 45 |
Evidence for the Existence of a Minimum of Two Phases of Ordered Water in Skeletal Muscle
Carlton F. Hazlewood, Buford Lee Nichols, Nugent F. Chamberlain · Nature
|
May 1969 |
321 |
| 46 |
Shale Alteration by Water Adsorption
Martin E. Chenevert · Journal of Petroleum Technology
Open access |
Sep 1970 |
314 |
| 47 |
Temperature Distribution in a Circulating Drilling Fluid
L.R. Raymond · Journal of Petroleum Technology
|
Mar 1969 |
312 |
| 48 |
Effect of pH on Interfacial Films and Stability of Crude Oil-Water Emulsions
J.E. Strassner · Journal of Petroleum Technology
|
Mar 1968 |
309 |
| 49 |
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
Christopher Ryan Heery, Geraldine O’Sullivan Coyne, Ravi Amrit Madan et al. · The Lancet Oncology
Open access |
31 Mar 2017 |
303 |
| 50 |
Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms
Céline Adessi · Nucleic Acids Research
Open access |
15 Oct 2000 |
300 |